Prerpints.org logo
Preprint
Review

This version is not peer-reviewed.

Probiotics Change the Microbiota: From the Lab to the Bedside

Submitted:

14 July 2023

Posted:

14 July 2023

You are already at the latest version

Abstract
Probiotics have become a potential way to change the microbiota, which allows for more personalized ways to improve health results. This abstract gives an outline of the most important parts of personalized microbiota regulation through probiotics. It focuses on effectiveness and mechanisms, clinical applications, safety and tolerability, formulations and delivery methods, and customized approaches. Many studies have looked into how and why probiotics change the microbiome. These studies show that probiotics can change the makeup and function of microbial communities. Probiotics have been shown to help treat a number of health problems, such as digestive problems, immune system problems, metabolic problems, and mental health problems. It is important for the success of probiotics to find out if they are safe and can be tolerated. Studies have shown that probiotics are usually safe for most people, but there are some things that need to be taken into account to make sure they are safe, especially for people who are weak. Formulations and transport methods are very important for making sure that probiotics are alive, stable, and delivered to the right places in the GI tract. Probiotic strains work better in the gut because of improvements in how probiotic preparation technologies protect and control the release of probiotic strains. Personalized methods take into account how each person's microbiome and health are different. By using individual microbiota profiling, custom probiotic approaches can be made to address specific microbial imbalances and promote a healthier microbial environment, which could improve treatment results. Even though individual methods show promise, there are still problems, such as the need to standardize microbiota profiling techniques, figure out how to understand data, and keep track of people over time. For personalized probiotics to reach their full potential and change the way patients are cared for based on the microbiota-host relationship, more study, technological advances, and teamwork are needed. In conclusion, probiotics can be used to change your microbiome in a way that is specific to you and your health goals. By using the power of individualized microbiota profiling, personalized probiotic treatments might be able to help with certain health problems and make the microbial environment better. Putting personalized probiotics into clinical practice and changing the way patients are cared for will require more study and partnerships between different fields.
Keywords: 
Microbiota
;  
probiotics
;  
formulations
;  
immune system
Subject: 
Biology and Life Sciences  -   Immunology and Microbiology

Introduction:

Probiotics are live bacteria that are good for your health when given in the right amounts. Their ability to change the makeup and function of the microbiota has brought them a lot of attention. Understanding how probiotics work and how effective they are important for making the best use of them as medicines. This subtopic looks at how well probiotics change the microbiome and how they do it 1-4.
Microbiota Modulation:
Several studies have shown that probiotics can change the makeup of the microbiome in the gut. Probiotics can support the growth of good bacteria, stop the growth of pathogens, and bring back microbial balance by interacting with the current microbial community. There is a lot of evidence that probiotics can change the way certain types of bacteria behave, such as by making more Bifidobacterium or Lactobacillus 4.
Changes in function:
In addition to changing the types of microbes, probiotics can also change how the microbiome works. They can speed up the metabolism of microorganisms, which can lead to the production of short-chain fatty acids (SCFAs) and antimicrobial peptides (AMPs). Probiotics can also change the function of the gut barrier, increase the immune reaction of the intestinal mucosa, and control the immune balance of the host. These changes in how the body works add to the overall health benefits of probiotics 5.
How these things work:
For a full understanding of how probiotics affect the microbiome, it is important to know how they work. Probiotics can have their effects in many ways, such as by competing for nutrients and places to stick, making antibacterial substances, changing how the host's immune system responds, and controlling how the host's genes are expressed. Also, probiotics can change how genes in microorganisms are expressed, which can change how they work and communicate. Evaluating how well probiotics change the makeup and function of the microbiome gives us important information about their medicinal potential. Understanding how probiotics work makes it possible to come up with focused treatments and personalized methods. More study is needed to figure out how probiotics and the microbiota work together so that they can be used most effectively to improve health and avoid or treat illnesses 6.
Uses in the clinic:
Probiotics are now being looked at as possible treatments for a wide range of health problems, beyond their usual use in GI health. This subtopic looks at how probiotics can be used in the clinic, with a focus on how they might help with digestive problems, problems with the immune system, problems with metabolism, and mental health problems 7.
Disorders of the intestines:
Probiotics have been studied a lot to see if they help stomach problems like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and diarrhea caused by antibiotics. Clinical studies have shown that certain types of probiotics can help relieve symptoms, improve the function of the gut barrier, change how the immune system responds, and restore microbial balance in people with these conditions 8.

Immune System Dysregulation:

Immune system dysfunction has brought attention to the fact that probiotics can change how the immune system works. Probiotics have shown potential in lowering the chance and severity of respiratory tract infections, allergic conditions, and autoimmune illnesses. They can change how immune cells work, boost oral immunity, and control how the immune system responds to inflammation, which could help treat immune-related diseases 9-11.
Metabolic Disorders:
Researchers have looked into what part probiotics might play in metabolic diseases like obesity, type 2 diabetes, and non-alcoholic fatty liver disease. Clinical studies have shown that certain types of probiotics can help people with these health problems with their glucose metabolism, lipid levels, and inflammatory markers. Probiotics may also affect the balance of energy and the way hormones are controlled in the gut, which could lead to new ways to treat metabolic health.
Disorders of the mind:
The gut-brain connection and the role of the microbiome in mental health are being studied more and more. Probiotics have been shown to help with anxiety, sadness, and other illnesses that are linked to stress. They can change how neurotransmitters are made, lower inflammation, and change how the gut and brain talk to each other, which could affect mental health. Probiotics can be used to treat a wide range of health problems that have nothing to do with the digestive system. Probiotics could help with digestive problems, problems with the immune system, problems with metabolism, and mental health problems. But more well-planned clinical studies are needed to find the best strains, doses, and treatment plans for different diseases. As research continues to figure out the complex interactions between the microbiota and human health, probiotics offer exciting opportunities for targeted interventions and personalized approaches in clinical practice. This personalized approach has the potential to improve treatment outcomes and patient satisfaction and well-being. Even though individual methods to changing the microbiota through probiotics hold a lot of promise, there are still some problems to solve. Standardizing microbiome tracking methods, figuring out what the data mean, and keeping track of things over time are all things that need more work. Also, combining multi-omics data and working together on study will help us learn more about the microbiota-microbe-host axis and make it easier to use custom probiotics in clinical settings. In conclusion, using probiotics to change the microbiota in a person's gut is a customized and focused way to improve health results. By using the power of individualized microbiota profiling, probiotic treatments can be made to address particular health problems and support a healthier microbial environment. To unlock the full potential of personalized probiotics and change patient care based on the microbiota-host relationship, more study, technological advances, and partnerships between different fields are needed 9-13.

Safety and Acceptableness:

As the number of people who use probiotics grows, it is important to look at how safe and well they work for different groups. This subtopic is about figuring out how safe and well probiotics work for different groups, like healthy people, babies, kids, the old, and people whose immune systems aren't working well 14-17.
Checking for safety:
To make sure that people who take probiotics are healthy, it is important to do a lot of research on how safe they are. To find out if probiotics are safe, clinical experiments, observational studies, and systematic reviews have been done. In these studies, side effects like stomach problems, infections, and problems with the whole body were looked at. Safety reviews also look at things like how the strain is made, how much it is used, how long it is used, and how it affects the host 14.
People who are healthy:
In healthy people, probiotics have been found to have a generally good safety rating. Most recorded side effects are mild and go away on their own, like temporary stomach problems. Clinical studies have shown that probiotics are safe for this group of people and don't cause any major safety issues 15.
Children and babies:
It is especially important that babies and kids can take probiotics without getting sick. Studies have shown that certain types of probiotics are safe for children, with only a small number of side effects. But probiotics may carry a small chance of infections, so they shouldn't be given to newborn babies or people with weak immune systems 15.
Elderly:
Due to age-related changes in immune function and underlying health problems, the needs of the old are often different from those of younger people. Studies have shown that probiotics are usually safe and well accepted by older people, and that bad side effects are rare. But when giving probiotics to this group of people, it's important to take into account how each person is different and any underlying health problems 16.
People with low immune systems:
Probiotics need to be carefully looked at in vulnerable people, such as those whose immune systems don't work well or who are getting treatments that weaken their immune systems. Even though most studies show that probiotics are safe, there are some worries about the chance of getting an infection. Because of this, people with weak immune systems should be careful when using probiotics and should tailor their use to their unique needs. Assessing the safety and acceptability of probiotics is important for making sure that they can be used correctly in a wide range of groups. Overall, probiotics have been shown to be safe for healthy people, babies, children, and even the old. But some people, like newborn babies and people whose immune systems aren't working well, need to be careful. Continued study and monitoring are needed to learn more about how safe and well-tolerated probiotics are and how they should be used in different groups of people. Taking a look at different probiotic forms and ways to get them into the body, such as pills, powders, and fermented foods. For probiotics to work and provide the health benefits that people want, they have to get to the intestines. This subtopic looks at different ways to make probiotics and get them to where they need to go in the GI tract. The goal is to improve the probiotics' survival, stability, and delivery to specific places 14-21.

Strategies for Making:

Formulating probiotics means choosing the right carriers or matrices to keep the live bacteria alive and stable during storage and travel through the digestive system. Enclosing something in a shell, microsphere, or bead can protect it from things like wetness, acidity, and bile salts in the environment. Other ways to make a drug include lyophilization, spray drying, or putting it into a powder, all of which can make it last longer and be easier to give 22-25.
Targeted Delivery:
Targeted transport methods try to get probiotics to certain parts of the digestive system, like the stomach or small intestine, where they can do their good work. Gastric acid and bile salts can destroy probiotics, but enteric covering or microencapsulation can keep them safe until they reach the lower gut. Also, new methods, such as bioadhesive formulations or encapsulation in hydrogels, make it easier to control the release of probiotics and stick them to particular parts of the gastrointestinal system 26-31.
Foods that go bad:
Fermented foods like yogurt, kefir, and pickles are good ways to get live probiotic microorganisms into your body. These traditional foods can make it easier for probiotics to live and grow by giving them a good place to live. People are already familiar with fermented foods, and they can be added to a normal diet to get probiotics in a way that is easy and generally acceptable 31-36.
Possible and Stable:
For probiotics to work, it is very important that they stay alive and stable during storage and absorption. To keep probiotics alive, they must be made and stored in the right way, with things like the right temperature and no moisture. Also, choosing the right probiotic types and figuring out how they interact with each other in the formulation can make them more stable and help them live through the digestive system. Formulations and delivery methods play a big part in making sure that probiotics are effective, stable, and get to the right place in the digestive tract. Advances in manufacturing techniques, such as encapsulation, focused delivery methods, and adding probiotics to fermented foods, can help make probiotics work better. More study is needed to find new ways to keep probiotics alive and get them to specific places in the digestive system. This will improve their therapeutic potential and health benefits in the long run. Investigating the role of individual microbiota profiles in choosing probiotics: The human microbiota is very varied and different for each person, which affects their health and sensitivity to disease. This subtopic is about personalized methods in the field of probiotics, with a focus on the role of individual microbiota analysis in guiding probiotic selection and treatment tactics. It looks at the possibility of personalized probiotic interventions that are based on a person's unique microbiome and health state 31-45.
Profiling the microbiota:
Microbiota profiling is a thorough study of a person's microbial communities that looks at the number and variety of different types of bacteria in the gut. Advanced methods like "next-generation sequencing" make it possible to get a detailed picture of the microbiome and learn about its makeup and how it might work. Microbiota analysis can help find microbial problems (called dysbiosis) and certain types of bacteria that are linked to health or disease 44.
Probiotic Choice:
Individualized microbiota analysis can help choose probiotics by pointing out which types of bacteria are missing or overrepresented in a person's gut microbiota. By knowing how a person's microbiota is made up and how it works, probiotics can be chosen to fix particular microbial imbalances and promote a healthier microbial environment. This personalized method to choosing probiotics aims to repair or improve the gut microbiota makeup of each person 45.
Personalized interventions with probiotics:
For personalized probiotic treatments, specific probiotic strains or mixtures are given to a person based on their microbiota and health state. By taking into account an individual's unique microbial makeup, personalized probiotics can address specific health conditions, such as gut disorders, immune dysregulation, metabolic disorders, or mental health problems. These individualized treatments are meant to restore microbial balance, improve interactions between the host and microbes, and improve health results generally 43.
Problems and things to think about:
Putting custom probiotic treatments into place is hard for a number of reasons. Because of how complicated the human microbiota is and how it interacts with the host, it is hard to come up with general rules for how to use probiotics in a specific way. Also, there needs to be a standard way to profile bacteria and figure out what it means, so that studies can be consistent and reliable. To figure out if individual probiotic programs work and are safe, they need to be tracked and followed up on for a long time 44.
Looking to the future:
Bioinformatics and microbiota profiling tools are getting better, which could help improve individual probiotic approaches. Integration of multi-omics data, such as metagenomics, metabolomics, and genetics of the host, can give a full picture of how different microbe markers are linked to health and disease. This personalized approach to probiotics has the ability to change clinical practice by allowing focused treatments that improve patient outcomes and make the most of the therapeutic effects.
Individualized microbiota profiling can help lead personalized methods to probiotics, which open up new ways to improve probiotic selection and treatment techniques. By tailoring probiotic treatments to an individual's unique microbiota makeup and health state, tailored probiotics have the potential to improve therapeutic results and promote individualized care. To solve obstacles and put personalized probiotics into clinical practice, we need to do more study and work together. This will improve tailored healthcare methods based on the microbiota-microbe-host axis 43-45.

Conclusion:

In conclusion, the idea of using probiotics to change the microbiome in a person's gut in a specific way is an exciting step forward in the field of health care. Personalized probiotic treatments could improve therapeutic results and patient care by taking into account each person's unique microbiota makeup and health state.
Many studies have been done on how and why probiotics change the microbiome. These studies show that probiotics can change the makeup and function of microbial communities. This knowledge opens the door for individual probiotic treatments that target specific microbial changes linked to different health problems, such as gastrointestinal disorders, immune dysregulation, metabolic disorders, and mental health disorders. It is important for the success of probiotics to test how safe and well they work in different groups. Studies have looked at the safety of probiotics in healthy people, babies, children, the elderly, and people with weakened immune systems. These studies show that probiotics are usually safe. But more study is needed to answer specific questions about safety and make sure that different groups of people can use probiotics safely. Formulations and transport methods are very important to the viability, stability, and targeted delivery of probiotics to specific areas in the GI tract. Advances in probiotic preparation technologies, like encapsulation and microencapsulation, make it easier to protect bacterial strains and control when they are released. These improvements make probiotics work better and get to where they need to be, so they can work best in the gut. The use of individual microbiome analysis to help choose probiotics is a big step forward in the field.

References

  1. Kilian, M.; Chapple, I.L.C.; Hannig, M.; Marsh, P.D.; Meuric, V.; Pedersen, A.M.L.; Tonetti, M.S.; Wade, W.G.; Zaura, E. The oral microbiome – an update for oral healthcare professionals. Br. Dent. J. 2016, 221, 657–666. [CrossRef]
  2. Scotti E, Boue S, Sasso GL, Zanetti F, Belcastro V, Poussin C, et al. (2017). Exploring the microbiome in health and disease: Implications for toxicology. Toxicology Research and Application, 1, 1-37. [CrossRef]
  3. Gao, L.; Xu, T.; Huang, G.; Jiang, S.; Gu, Y.; Chen, F. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell 2018, 9, 488–500. [CrossRef]
  4. Yamashita, Y.; Takeshita, T. The oral microbiome and human health. J. Oral Sci. 2017, 59, 201–206. [CrossRef]
  5. Lane N. (2015). The unseen world: Reflections on Leeuwenhoek (1677) ‘concerning little animals’. Philosophical Transactions of the Royal Society B: Biological Sciences, 370, 20140344. [CrossRef]
  6. Patil S, Rao RS, Amrutha N, Sanketh DS. (2013). Oral microbial flora in health. World Journal of Dentistry, 4, 262-266. [CrossRef]
  7. Ezaura, E.; Nicu, E.A.; Krom, B.P.; Keijser, B.J.F. Acquiring and maintaining a normal oral microbiome: current perspective. Front. Cell. Infect. Microbiol. 2014, 4, 85. [CrossRef]
  8. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, et al. (2010). The human oral microbiome. Journal of Bacteriology, 192, 5002-5017. [CrossRef]
  9. Zhao, H.; Chu, M.; Huang, Z.; Yang, X.; Ran, S.; Hu, B.; Zhang, C.; Liang, J. Variations in oral microbiota associated with oral cancer. Sci. Rep. 2017, 7, 11773. [CrossRef]
  10. Lim, Y.; Totsika, M.; Morrison, M.; Punyadeera, C. Oral Microbiome: A New Biomarker Reservoir for Oral and Oropharyngeal Cancers. Theranostics 2017, 7, 4313–4321. [CrossRef]
  11. Sowmya Y. (2016). A review on the human oral microflora. Research Reviews: Journal of Dental Sciences, 4, 1-5.
  12. Marsh PD. (2009). Role of the oral microflora in health. Microbial Ecology in Health and Disease, 12, 130-137. [CrossRef]
  13. Batabyal B, Chakraborty S, Biswas S. (2012). Role of the oral microflora in human population: A brief review. International Journal of Pharmacy and Life Sciences, 3, 2220-2227.
  14. Sampaio-Maia, B.; Monteiro-Silva, F. Acquisition and maturation of oral microbiome throughout childhood: An update. Dent. Res. J. 2014, 11, 291–301.
  15. Könönen, E. Development of oral bacterial flora in young children. Ann. Med. 2000, 32, 107–112. [CrossRef]
  16. Palmer RJ Jr. (2014). Composition and development of oral bacterial communities. Periodontology 2000, 64, 20-39. [CrossRef]
  17. Demmitt, B.A.; Corley, R.P.; Huibregtse, B.M.; Keller, M.C.; Hewitt, J.K.; McQueen, M.B.; Knight, R.; McDermott, I.; Krauter, K.S. Genetic influences on the human oral microbiome. BMC Genom. 2017, 18, 659. [CrossRef]
  18. Zarco, M.; Vess, T.; Ginsburg, G. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis. 2012, 18, 109–120. [CrossRef]
  19. Benn, A.; Heng, N.; Broadbent, J.; Thomson, W. Studying the human oral microbiome: challenges and the evolution of solutions. Aust. Dent. J. 2018, 63, 14–24. [CrossRef]
  20. Aas, J.A.; Paster, B.J.; Stokes, L.N.; Olsen, I.; Dewhirst, F.E. Defining the Normal Bacterial Flora of the Oral Cavity. J. Clin. Microbiol. 2005, 43, 5721–5732. [CrossRef]
  21. McLean, J.S. Advancements toward a systems level understanding of the human oral microbiome. Front. Cell. Infect. Microbiol. 2014, 4, 98. [CrossRef]
  22. Malla, M.A.; Dubey, A.; Kumar, A.; Patil, A.; Ahmad, S.; Kothari, R.; Yadav, S. Optimization and elucidation of organophosphorus and pyrethroid degradation pathways by a novel bacterial consortium C3 using RSM and GC-MS-based metabolomics. J. Taiwan Inst. Chem. Eng. 2023, 144, 104744. [CrossRef]
  23. Munot, N.; Kandekar, U.; Rikame, C.; Patil, A.; Sengupta, P.; Urooj, S.; Bilal, A. Improved Mucoadhesion, Permeation and In Vitro Anticancer Potential of Synthesized Thiolated Acacia and Karaya Gum Combination: A Systematic Study. Molecules 2022, 27, 6829. [CrossRef]
  24. Munot, N.; Kandekar, U.; Giram, P.S.; Khot, K.; Patil, A.; Cavalu, S. A Comparative Study of Quercetin-Loaded Nanocochleates and Liposomes: Formulation, Characterization, Assessment of Degradation and In Vitro Anticancer Potential. Pharmaceutics 2022, 14, 1601. [CrossRef]
  25. Manikyam, H.K.; Tripathi, P.; Patil, S.B.; Lamichhane, J.; Chaitanya, M.; Patil, A.R. Extraction, purification, and quantification of hesperidin from the immature Citrus grandis/maxima fruit Nepal cultivar. Asian J. Nat. Prod. Biochem. 2022, 20. [CrossRef]
  26. Patil, A.; Munot, N.; Patwekar, M.; Patwekar, F.; Ahmad, I.; Alraey, Y.; Alghamdi, S.; Kabrah, A.; Dablool, A.S.; Islam, F. Encapsulation of Lactic Acid Bacteria by Lyophilisation with Its Effects on Viability and Adhesion Properties. Evidence-Based Complement. Altern. Med. 2022, 2022, 1–9. [CrossRef]
  27. Nalawade AS, Gurav RV, Patil AR, Patwekar M, Patwekar F. (2022). A comprehensive review on morphological, genetic and phytochemical diversity, breeding and bioprospecting studies of genus Chlorophytum Ker Gawl. from India. Trends in Phytochemical Research. 6(1):19-45.
  28. Patil KG, Balkundhi S, Joshi H, Ghewade G. (2011). MEHSANA BUFFALO MILK AS PREBIOTICS FOR GROWTH OF LACTOBACILLUS. International Journal of Pharmacy and Pharmaceutical Research. 1(1):114-117.
  29. Das, N.; Ray, N.; Patil, A.R.; Saini, S.S.; Waghmode, B.; Ghosh, C.; Patil, S.B.; Patil, S.B.; Mote, C.S.; Saini, S.; et al. Inhibitory effect of selected Indian honey on colon cancer cell growth by inducing apoptosis and targeting the β-catenin/Wnt pathway. Food Funct. 2022, 13, 8283–8303. [CrossRef]
  30. Patil MJ, Mali V. (2021). The Diverse Cytotoxicity Evaluation of Lactobacillus Discovered from Sheep Milk. Acta Scientific Pharmaceutical Sciences. 5(12):69-70.
  31. Abhinandan P SP, John D. (2020). Probiotic potential of Lactobacillus plantarum with the cell adhesion properties. Journal of Global Pharma Technology. 10(12):1-6.
  32. Patil A, Pawar S, Disouza J. (2018). Granules of unistrain lactobacillus as nutraceutical antioxidant agent. International Journal of Pharmaceutical Sciences and Research. 9(4):1594-1599.
  33. Patil, A.; Mali, V.; Patil, R.; Foundation, K.4.L.I.S. Banana fibers camouflaging as a gut worm in a 6-month-old infant. Iberoam. J. Med. 2020, 2, 245–247. [CrossRef]
  34. 34. Munot NM, Shinde YD, Shah P, Patil A, Patil SB, Bhinge SD. (2021). Formulation and Evaluation of Chitosan-PLGA Biocomposite Scaffolds Incorporated with Quercetin Liposomes Made by QbD Approach for Improved Healing of Oral Lesions. AAPS PharmSciTech. 24(6):147. [CrossRef]
  35. Patil A. (2023). Psychology in the Age of Technology Dependence and the Mobile Dilemma. Preprints.org. 2023070101. [CrossRef]
  36. Patil A, Kotekar D, Chavan G. (2023). Knowing the Mechanisms: How Probiotics Affect the Development and Progression of Cancer. Preprints.org. 2023070243. [CrossRef]
  37. Pawar, V.; Patil, A.; Tamboli, F.; Gaikwad, D.; Mali, D.; Shinde, A. Harnessing the Power of AI in Pharmacokinetics and Pharmacodynamics: A Comprehensive Review. AAPS PharmSciTech 2023, 14, 426–439. [CrossRef]
  38. Malla, M.A.; Dubey, A.; Kumar, A.; Patil, A.; Ahmad, S.; Kothari, R.; Yadav, S. Optimization and elucidation of organophosphorus and pyrethroid degradation pathways by a novel bacterial consortium C3 using RSM and GC-MS-based metabolomics. J. Taiwan Inst. Chem. Eng. 2023, 144, 104744. [CrossRef]
  39. 39. Singh N,Mishra DK, Bhange K, Patil AR, Potential gene targets for schizophrenia detection through molecular techniques: A review. (2023) Receptor 3 (6p22), 6p22.
  40. Dhane, K.; Gupta, M.K.; Hyam, S.; Patil, A. Preparation and in-vitro and in-vivo Evaluation of Ayurvedic Formulation “Amruthotharam” Formulated by Classical and Modern Technique. Indian J. Pharm. Educ. Res. 2023, 57, s126–s134. [CrossRef]
  41. Nitish Pathak, Shams Tabrez Siddiqui, Anjani Kumar Singha, Heba G Mohamed, Shabana Urooj, Abhinandan R Patil, Smart quarantine environment privacy through IoT gadgets using blockchain. (2023), Intell Autom Soft Comput (Accepted).
  42. Pawar S Patil A, Mote C, Kulkarni S, Upadhye A, Disouza J, Genomic-Based Restriction Enzyme Selection for Specific Detection of Lactobacillus rhamnosus and Lactobacillus plantarum strain by 16S rDNA PCR-RFLP. (2020), International Journal of Innovative Science, Engineering and Technology, 1 (1), 91-99.
  43. Patil R, Patil A. The role of the food and fertilizers in antimicrobial resistance in human and its preventive measures. (2020), International Journal of Innovative Science, Engineering and Technology, 1 (1), 31-37.
  44. Pawar S, Patil A, Disouza J, Dhavalshankh A, Mote C. Isolation and characterisation of Lactobacillus species from sheep milk. (2020) International Journal of Innovative Science Engineering and Technology, (GETAR conference proceeding), 1 (1), 9-17.
  45. Pawar S, Patil A, Disouza J Use of Probiotics as a Functional Food against Cancer. (2019) Acta Scientific Pharmaceutical Sciences. 3 (8), 103-105. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
bsky
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated